Metabolic Surgery Improves Diabetes-Related Quality of Life Metabolic Surgery Improves Diabetes-Related Quality of Life
Significant weight loss and lack of need for insulin after metabolic surgery drive improvements in health and quality of life, but patients may still lack psychosocial support.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 4, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Dubai ’s GluCare first outside of US to secure URAC RPM accreditation
Earlier this year, the specialist diabetes centre released its first report that indicated that patients using its Remote Patient Monitoring plan achieved an average HbA1c reduction of 1.7% points over 90 days. (Source: mobihealthnews)
Source: mobihealthnews - August 4, 2021 Category: Information Technology Source Type: news

Half Abandon Metformin Within a Year of Diabetes Diagnosis Half Abandon Metformin Within a Year of Diabetes Diagnosis
Multiple factors blamed for the drop-off, while improved communication, follow-up, and medication adjustment advised as remedies.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - August 3, 2021 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

Half Abandon Metformin Within a Year of Diabetes
Diagnosis (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 3, 2021 Category: General Medicine Source Type: news

US FDA grants Priority Review to Roche ’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Basel, 3 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-appro ved test. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, which aims to explore a more efficient review process to ensure safe and ef...
Source: Roche Media News - August 3, 2021 Category: Pharmaceuticals Source Type: news

US FDA grants Priority Review to Roche ’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Basel, 3 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-appro ved test. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, which aims to explore a more efficient review process to ensure safe and ef...
Source: Roche Investor Update - August 3, 2021 Category: Pharmaceuticals Source Type: news

Text-message ‘nudges’ can encourage holdouts to get COVID vaccination, study finds
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.The researchers, from theDavid Geffen School of Medicine at UCLA, theUCLA Anderson School of Management and Carnegie Mellon University, say their findings held true across all demographics, including groups that have been hesitant to receive the vaccine.“We found that text messages that stressed the accessibility of the vaccine and that included ‘ownership’ language — such as ‘The vaccine has just been made available for you...
Source: UCLA Newsroom: Health Sciences - August 3, 2021 Category: Universities & Medical Training Source Type: news

Diabetes prevention programme re-procurement
The healthier you NHS diabetes prevention programme supports those identified in general practice at high risk of type 2 diabetes by referral onto a behaviour change programme. (Source: NHS Networks)
Source: NHS Networks - August 3, 2021 Category: UK Health Source Type: news

Low-carb diet WON'T harm your kidneys, new study suggests
Studies have shown that a low-carb (less than 130g a day), higher-protein diet can actually be beneficial for people with type 2 diabetes. It could even reverse their condition as one study suggested. (Source: the Mail online | Health)
Source: the Mail online | Health - August 2, 2021 Category: Consumer Health News Source Type: news

Type 2 diabetes: Oedema in your hands, feet, ankles or legs are a sign of high blood sugar
CONSISTENTLY high blood sugar will lead to disastrous health complications, including diabetic nephropathy - the deterioration of the kidneys. This condition is said to affect 40 percent of those with type 2 diabetes. (Source: Daily Express - Health)
Source: Daily Express - Health - August 2, 2021 Category: Consumer Health News Source Type: news

High-Deductible Health Plans Tied to Rx Nonadherence in Diabetes
MONDAY, Aug. 2, 2021 -- High-deductible health plans (HDHPs) are associated with greater cost-related medication nonadherence (CRN) among adults with diabetes, according to a study published online July 29 in the Journal of General Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 2, 2021 Category: Pharmaceuticals Source Type: news

Testosterone Therapy for Hypogonadism With Diabetes? Testosterone Therapy for Hypogonadism With Diabetes?
Nonrandomized 12-year data do not provide hard conclusions about testosterone benefit vs risk for men with low T and diabetes; one RCT has been published, but the jury is still out on safety.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 2, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone[1] every minute with optional real-time glucose alarms[2] The FreeStyle Libre 2 app enables kids (ages 4 and olde... Devices, Monitoring, Endocrinology, FDA Abbott, FreeStyle Libre 2, glucose monitor, iOS app (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 2, 2021 Category: Pharmaceuticals Source Type: news

Abbott's FreeStyle ® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
- FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone[1] every minute with optional real-time glucose alarms[2] (Source: Abbott.com)
Source: Abbott.com - August 2, 2021 Category: Pharmaceuticals Source Type: news

How Will Delta and COVID-19 Change This Back-to-School Season? Here ’s What to Know
Getting the kids ready to go back to school each fall is stressful enough in a normal year, never mind in the midst of a pandemic. Between the more transmissible Delta coronavirus variant, rising cases across the country and new masking guidance from the U.S. Centers for Disease Control and Prevention (CDC), there’s a lot for parents to navigate as they plan for schools to reopen this August and September. On the whole, experts seem to agree it’s time to get kids back into their classrooms. Remote learning set many children—especially students of color—back academically, cut them off from essential ...
Source: TIME: Health - August 2, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news

Diabetes type 2: The subtle signs of high blood sugar you 'may not notice' - expert
ONE in 10 people over the age of 40 is now living with a diagnosis of Type 2 diabetes in the UK. The charity Diabetes UK has warned the UK is facing a ‘diabetes timebomb' after nearly 2.5 million sufferers missed check ups during the pandemic. Researchers have identified signs of 'hidden diabetes' that could prevent the condition from developing altogether. (Source: Daily Express - Health)
Source: Daily Express - Health - August 2, 2021 Category: Consumer Health News Source Type: news

Abbott's FreeStyle Libre 2 app snags FDA clearance to help users manage diabetes
The new system can be used with Apple iPhones and lets users check their glucose without needing a reader.   (Source: mobihealthnews)
Source: mobihealthnews - August 2, 2021 Category: Information Technology Source Type: news

A new paradigm of diabetes care
How innovation has been a game changer for diabetes patients.   (Source: mobihealthnews)
Source: mobihealthnews - August 2, 2021 Category: Information Technology Source Type: news

Fat Tissue Reorganizes During Pregnancy
Researchers identify a protein that promotes changes in adipose tissue in vitro and in pregnant mice and may help protect against gestational diabetes in humans. (Source: The Scientist)
Source: The Scientist - August 1, 2021 Category: Science Tags: The Literature Magazine Issue Source Type: news

Monthly News Roundup - July 2021
Kerendia Cleared to Treat Chronic Kidney Disease Linked with Type 2 Diabetes In July, the FDA approved Bayer’s Kerendia (finerenone) from Bayer, a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist (MRA) for the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2021 Category: Pharmaceuticals Source Type: news

Diabetes Drug's New Weight Loss Formula Fuels Cost-Benefit Debate Diabetes Drug's New Weight Loss Formula Fuels Cost-Benefit Debate
Diabetes drugs are being reformulated and renamed as new obesity treatments. Medicare currently doesn't cover the latter, and private insurers will have to decide if the cost is worth the benefit.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Family Doctors Omit Tests for Kidney Disease in Type 2 Diabetes Family Doctors Omit Tests for Kidney Disease in Type 2 Diabetes
US primary care physicians are not properly checking patients with type 2 diabetes for chronic kidney disease nearly as often as they should, meaning many miss getting a timely diagnosis.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 30, 2021 Category: Cardiology Tags: Nephrology News Source Type: news

When Deductibles Rise, More Diabetes Patients Skip Their Meds
FRIDAY, July 30, 2021 -- As many Americans know, today's health insurance plans often come with high deductibles. Those out-of-pocket costs could cause harm: New research shows that 20% of people who have diabetes and high-deductible health plans... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 30, 2021 Category: General Medicine Source Type: news

Effects of Testosterone Treatment on Blood Pressure in Men Effects of Testosterone Treatment on Blood Pressure in Men
A new study examines the impacts of testosterone therapy, alone and in combination with exercise, on ambulatory blood pressure among older men.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Type 2 Diabetes in Teens Can Bring Dangerous Complications in 20s
Title: Type 2 Diabetes in Teens Can Bring Dangerous Complications in 20sCategory: Health NewsCreated: 7/29/2021 12:00:00 AMLast Editorial Review: 7/30/2021 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - July 30, 2021 Category: Endocrinology Source Type: news

When Deductibles Rise, More Diabetes Patients Skip Their Meds
Title: When Deductibles Rise, More Diabetes Patients Skip Their MedsCategory: Health NewsCreated: 7/30/2021 12:00:00 AMLast Editorial Review: 7/30/2021 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - July 30, 2021 Category: Endocrinology Source Type: news

Health Care Heroes 2021: Claudia P. Neira, chief clinical officer of LifeDoc Health
“Claudia has committed her career to serving her patients and walking hand in hand with them as they battle diabetes and other chronic issues.” (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 30, 2021 Category: Biotechnology Authors: Susan Ellis Source Type: news

Health Care Heroes 2021: Claudia P. Neira, chief clinical officer of LifeDoc Health
“Claudia has committed her career to serving her patients and walking hand in hand with them as they battle diabetes and other chronic issues.” (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 30, 2021 Category: American Health Authors: Susan Ellis Source Type: news

FDA Approves First Biosimilar Insulin Product
THURSDAY, July 29, 2021 -- The first interchangeable biosimilar insulin product has been approved by the U.S. Food and Drug Administration, providing patients with a cost-effective option for treating diabetes, the agency announced... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2021 Category: Pharmaceuticals Source Type: news

Certain Gut Bacteria Tied to Lower Risk of Diabetes Certain Gut Bacteria Tied to Lower Risk of Diabetes
Greater gut microbial diversity and abundance of 12 types of butyrate-producing bacteria may hinder the development of type 2 diabetes, a population-based study in the Netherlands hints.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 29, 2021 Category: Gastroenterology Tags: Diabetes & Endocrinology News Source Type: news

Diabetes type 2 symptoms: Three subtle warning signs of high blood sugar in your hands
DIABETES type 2 can be ferocious if blood sugar levels are not contained. Nerve damage is a common casualty of consistently high blood sugar levels, three signs of which can show up in your hands. (Source: Daily Express - Health)
Source: Daily Express - Health - July 29, 2021 Category: Consumer Health News Source Type: news

National diabetes study featured investigators and patients from Upstate's Joslin Diabetes Center
Findings show serious complications from youth-onset type 2 diabetes arise by young adulthood, underscoring importance of early, intensive treatment (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - July 29, 2021 Category: Universities & Medical Training Tags: Research Source Type: news

What is brittle diabetes? How condition differs from typical Type 1 and 2
DIABETES is an often lifelong affliction, depending on the type people develop, and can prove tough to treat. One of the rarest forms is brittle diabetes, but what is it? (Source: Daily Express - Health)
Source: Daily Express - Health - July 29, 2021 Category: Consumer Health News Source Type: news

Home care operator to launch skilled nursing services in Clayton
New services will include medication management and administration, wound care and dressing changes, monitoring of vital signs, diabetic care and oxygen treatments. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 29, 2021 Category: American Health Authors: Jacob Fisher Source Type: news

Long-Term Complications Common With Youth-Onset T2DM
THURSDAY, July 29, 2021 -- For individuals with onset of type 2 diabetes in youth, complications increase steadily over time, affecting many by the time of young adulthood, according to a study published in the July 29 issue of the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2021 Category: Pharmaceuticals Source Type: news

Type 2 Diabetes in Teens Can Bring Dangerous Complications in 20s
THURSDAY, July 29, 2021 -- Children diagnosed with type 2 diabetes face a high likelihood of developing complications before age 30, a new study suggests. Researchers found that among 500 children and teenagers with type 2 diabetes, 60% developed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2021 Category: General Medicine Source Type: news

New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations
- Patients with diabetes who did not meet the recommended daily intake of protein had greater physical limitations, which together may suggest an increased risk of muscle loss (Source: Abbott.com)
Source: Abbott.com - July 29, 2021 Category: Pharmaceuticals Source Type: news

FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
The U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. Semglee (insulin glargine-yfgn) is both biosimilar to, and interchangeable with (can be substituted for), its reference product Lantus (insulin glargine), a long-acting insulin analog. (Source: World Pharma News)
Source: World Pharma News - July 29, 2021 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA OKs Automatic Use of a Cheaper Generic Insulin
Title: FDA OKs Automatic Use of a Cheaper Generic InsulinCategory: Health NewsCreated: 7/29/2021 12:00:00 AMLast Editorial Review: 7/29/2021 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - July 29, 2021 Category: Endocrinology Source Type: news

Diabetes type 2: Five warning signs in the morning your blood sugar levels are too high
DIABETES type 2 is a complicated condition and as such a person suffering may be unaware of how their blood sugar levels can alter throughout the day. The morning time is the most crucial point for a diabetic to ensure their blood sugars are healthy as the dawn phenomenon could have an impact on their body throughout the day. What are the five main symptoms indicating your blood sugars are too high in the morning? (Source: Daily Express - Health)
Source: Daily Express - Health - July 29, 2021 Category: Consumer Health News Source Type: news

Cyclic Cushing's Disease With Improved Psoriatic Lesions Cyclic Cushing's Disease With Improved Psoriatic Lesions
In this case, a patient with Cushing's disease realized dramatic improvements in psoriatic skin lesions during an episode of hypercortisolemia.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 29, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

FDA accepts application for Roche ’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Basel, 29 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company’s submission for diabetic retinopathy.Faricimab will be the first and only bispecific antibody designed for the eye, if approved. It targets two distinct pathways – via angiopoietin-2 (Ang-2) and vascular endothelial growt...
Source: Roche Media News - July 29, 2021 Category: Pharmaceuticals Source Type: news

FDA accepts application for Roche ’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Basel, 29 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company’s submission for diabetic retinopathy.Faricimab will be the first and only bispecific antibody designed for the eye, if approved. It targets two distinct pathways – via angiopoietin-2 (Ang-2) and vascular endothelial growt...
Source: Roche Investor Update - July 29, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves First Interchangeable Biosimilar Insulin FDA Approves First Interchangeable Biosimilar Insulin
Semglee is now both biosimilar to glargine and also interchangeable with Lantus, so it can be substituted at the pharmacy.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 29, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

' Shocking' Early Complications From Teen-Onset Type 2 Diabetes'Shocking' Early Complications From Teen-Onset Type 2 Diabetes
Almost two thirds of study participants had at least one diabetes complication in young adulthood, around 15 years after diagnosis. A handful died, including one from heart attack and one due to kidney failure.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 29, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Biocon's interchangeable insulin Semglee gets US FDA approval
Biocon partnered with global healthcare company Viatris Inc to develop Semglee, the first interchangeable biosimilar product approved in the United States to treat diabetic patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2021 Category: Pharmaceuticals Source Type: news

Biocon Biologics interchangeable insulin Semglee gets US FDA approval
Biocon partnered with global healthcare company Viatris Inc to develop Semglee, the first interchangeable biosimilar product approved in the United States to treat diabetic patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Semglee (insulin glargine-yfgn) as the First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes
SILVER SPRING, Md., July 28, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 28, 2021 Category: Drugs & Pharmacology Source Type: news

Serious complications from youth-onset type 2 diabetes arise by young adulthood
Findings from NIH-funded study underscore importance of early, intensive treatment (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 28, 2021 Category: American Health Source Type: news

' Staggering' Increase in Global Dementia Cases Predicted by 2050'Staggering' Increase in Global Dementia Cases Predicted by 2050
Increased access to education around the world may help drive down dementia cases, but the gains could be wiped out by increases in smoking, obesity, and diabetes, experts say.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - July 28, 2021 Category: Primary Care Tags: Psychiatry News Source Type: news